Key result
12-month DOAC therapy linked to complete resolution of pulmonary vein thrombosis in a case report.
Why the study?
Pulmonary vein thrombosis is a rare but potentially lethal source of arterial thromboembolism, presenting diagnostic challenges and varied management options.
Case Report (n=1)
Direct oral anticoagulant therapy successfully resolved a rare case of pulmonary vein thrombosis in a patient presenting with chest pain.
May support DOAC consideration in pulmonary vein thrombosis; leaves open need for prospective validation.
Pulmonary vein thrombosis (PVT) is a rare but potentially lethal source of arterial thromboembolism. We present a case of a 59-year-old female patient who presented with worsening shortness of breath and was found on a cardiac computed tomography angiography (CTA) with the right lower pulmonary vein partially occluded with a filling defect. This case report highlights the diagnostic challenges and management options associated with this rare entity.
No takes yet. Share an insight, caveat, or question.
Vicenty-Rivera et al. (2024) conducted a case report in Pulmonary vein thrombosis (n=1). Direct oral anticoagulants (DOAC) was evaluated on Resolution of thrombus. Treatment with direct oral anticoagulants for 12 months led to the complete resolution of pulmonary vein thrombosis in a 57-year-old female presenting with chest pain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: